Abstract
Sleep disturbances due to medications is a common problem. The effects can vary from mild insomnia to major alterations in sleep architecture. The factors affecting the sleep disturbances can be related to the patient or the drug. In this review article we have focused on the side effects due to medication commonly used in pulmonary medicine. The group of drugs discussed are corticosteroids, bronchodilators, leukotriene antagonists, methylxanthines, antihistamines, immunosuppressive medications and prostaglandins. Most evidence comes from studies involving small number of healthy volunteers, retrospective reports, or sleep disturbance reported during clinical trials. Though most of these medications have the potential to cause sleep disturbances, they may actually promote better sleep by improving the respiratory symptoms, especially in asthmatics and COPD patients. It is important that the clinician needs to be aware of these side effects so that the effects can be minimized by making appropriate adjustments to the drugs, making the patient aware of the side effects, counseling on good sleep hygiene and behavioral changes.
Keywords: Insomnia, sleep disturbances, medications, drugs, pulmonary drugs
Current Respiratory Medicine Reviews
Title: Sleep Disturbances Due to Pulmonary Medications
Volume: 5 Issue: 4
Author(s): Raghu M. Reddy and Shyamsunder Subramanian
Affiliation:
Keywords: Insomnia, sleep disturbances, medications, drugs, pulmonary drugs
Abstract: Sleep disturbances due to medications is a common problem. The effects can vary from mild insomnia to major alterations in sleep architecture. The factors affecting the sleep disturbances can be related to the patient or the drug. In this review article we have focused on the side effects due to medication commonly used in pulmonary medicine. The group of drugs discussed are corticosteroids, bronchodilators, leukotriene antagonists, methylxanthines, antihistamines, immunosuppressive medications and prostaglandins. Most evidence comes from studies involving small number of healthy volunteers, retrospective reports, or sleep disturbance reported during clinical trials. Though most of these medications have the potential to cause sleep disturbances, they may actually promote better sleep by improving the respiratory symptoms, especially in asthmatics and COPD patients. It is important that the clinician needs to be aware of these side effects so that the effects can be minimized by making appropriate adjustments to the drugs, making the patient aware of the side effects, counseling on good sleep hygiene and behavioral changes.
Export Options
About this article
Cite this article as:
Reddy M. Raghu and Subramanian Shyamsunder, Sleep Disturbances Due to Pulmonary Medications, Current Respiratory Medicine Reviews 2009; 5 (4) . https://dx.doi.org/10.2174/157339809790112393
DOI https://dx.doi.org/10.2174/157339809790112393 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progress Towards Discovery of Antifibrotic Drugs Targeting Synthesis of Type I Collagen
Current Medicinal Chemistry Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued) Nitric Oxide-Mediated Endothelial Dysfunction - Is there Need to Treat?
Current Vascular Pharmacology Hydrochlorothiazide vs. Chlorthalidone as the Optimal Diuretic for the Management of Hypertension
Current Pharmaceutical Design Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Fractional Flow Reserve: Physiological Basis, Advantages and Limitations, and Potential Gender Differences
Current Cardiology Reviews Molecular Basis of Cardioprotection by Erythropoietin
Current Molecular Pharmacology Sympathetic Overactivity in Patients with Chronic Renal Failure - The Culprit of Increased Cardiovascular Mortality?
Current Hypertension Reviews Left Ventricular Non-compaction: From Recognition to Treatment
Current Pharmaceutical Design Proteomics to Unravel Platelet-Related Diseases and Identify Novel Anti-Platelet Drugs
Current Medicinal Chemistry The Effect of SEX/Gender on Cardiovascular Pharmacology
Current Pharmaceutical Design Xanthine Oxidase Inhibitor Febuxostat as a Novel Agent Postulated to Act Against Vascular Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?
Current Vascular Pharmacology Cardiovascular Disease and Dyslipidemia: Beyond LDL
Current Pharmaceutical Design Cardiovascular Disease in Masked Hypertension: Clinical Implications
Current Hypertension Reviews Gum-Chewing and Headache: An Underestimated Trigger of Headache Pain in Migraineurs?
CNS & Neurological Disorders - Drug Targets Introduction from the Guest Editor: The Many Facets of Heme Oxygenase
Current Neurovascular Research Targeting Small Arteries of Hypertensive Status with Novel ATP-Sensitive Potassium Channel Openers&#
Current Vascular Pharmacology Troponin in Newborns and Pediatric Patients
Cardiovascular & Hematological Agents in Medicinal Chemistry Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology